Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: State University of New York at Buffalo
• Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)
• Treatments: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Methadone; Naloxone

Criteria

Inclusion Criteria:

• chronic back pain

• opioid addiction

• not successful with abstinence

• at least 18 years old

• able to understand spoken English

• live in Western New York State (Erie or Niagara county)

• have health insurance or ability to pay for health care

• no methadone or buprenorphine treatment within past year

• not member of a vulnerable population (e.g., pregnancy, prisoner)

Exclusion Criteria:

• homelessness

• unable to give consent (e.g., dementia, psychosis)

• serious heart or lung disease

• taking a medication that could interact with methadone or buprenorphine

• pregnancy